Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00295139
Status:
COMPLETED
Last Update Posted:
2022-02-18
First Post:
2006-02-19
Brief Title:
Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness SPMI Patients
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
Behavioral Treatment of Drug Abuse in SPMI Patients
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main purpose of this study is to determine if the multifaceted treatment for substance abuse in dual disordered patients is more effective in reducing drug use than a supportive control treatment The researchers will also determine if adding a case management component Critical Time Intervention CTI to the intervention will increase treatment engagement and retention
Detailed Description:
Drug and alcohol abuse by people with severe and persistent mental illness SPMI is one of the most significant problems facing the public mental health system We have been conducting a project to develop a multifaceted treatment for substance abuse in dual disordered patients Behavioral Treatment for Substance Abuse in Schizophrenia BTSAS Results have shown that the treatment is well-accepted by patients and has a significant effect on drug use While BTSAS has been effective at retaining subjects and fostering reduced drug use a major problem that occurred was low rates of engagement The main purpose of this study is to determine if BTSAS is more effective in reducing drug use than a supportive control treatment and to determine if adding a case management component Critical Time Intervention CTI will increase treatment engagement and retention in BTSAS
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None